Archives

by in
Entry Author Date Location
Raleigh-Durham Roundup: MaxPoint, Targacept, Frontier Capital, & More 03/09/15 Raleigh Durham
Well-Funded NGM Bio Nabs $200M To Boost Merck’s Metabolic Pipeline 02/23/15 San Francisco
Why Boston Biotech Should Look to London 02/09/15 Boston
West Coast Biotech Roundup: Zymeworks, Lee Hood, Sue Biggins, Nektar 01/22/15 Seattle
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
More Green For Moderna as Merck Makes $50M Equity Grab, mRNA Deal 01/13/15 Boston
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
With Massive Venture Round, Moderna Has $450M Reasons to Stay Private 01/05/15 Boston
Famed Geneticist Altshuler Bolts Broad Institute for Vertex 12/15/14 Boston
Clovis Shares Drop Following Release of Cancer-Drug Trial Data 11/19/14 Boulder/Denver
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Struggling Aegerion Diversifies With Fat Disease Drug 11/06/14 Boston
Raleigh-Durham Roundup: Targacept, Chimerix, Red Hat, & More 10/13/14 Raleigh Durham
Smart-Bug Maker Synlogic Nabs $5M From Gates Foundation 10/07/14 Boston
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
Alios’s Corporate Venture Backers Ride RSV (And Hep C) To Big Payday 10/01/14 San Francisco
West Coast Biotech Roundup: Halozyme, Nektar, Allozyne, Novo & More 09/18/14 Seattle
Merck, Leapfrogging Bristol-Myers, Wins FDA Nod for Cancer Drug 09/04/14 New York
Emulate Scores $12M to Shake Up Drug Testing With Organs on Chips 07/28/14 Boston
G1, Out to Shield Body From Chemo, Heads to First Clinical Test 07/28/14 Raleigh Durham
Stealth Mode is the New Sweet Spot for Some Biotechs 07/14/14 National
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Moderna, Changing Its Identity, Plots Army of mRNA Spinouts 06/12/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
Post-IPO Biotechs Have News, But Big Pharma Drives the ASCO Boat 06/06/14 Boston
Clovis Shares Tumble as Analysts Give Edge to Lung-Cancer Rival 06/04/14 Boulder/Denver
Promedior Sees Hope in Small Myelofibrosis Study 05/30/14 Boston
Page 1 of 7 next page »